[1] |
中华医学会结核病学分会,《中华结核和呼吸杂志》编辑委员会. 非结核分枝杆菌病诊断与治疗专家共识. 中华结核和呼吸杂志, 2020, 43(11):918-946. doi:10.3760/cma.j.cn112147-20200508-00570.
|
[2] |
Kumar K, Ponnuswamy A, Capstick TG, et al. Non-tuberculous mycobacterial pulmonary disease (NTM-PD):Epidemiology,diagnosis and multidisciplinary management. Clin Med (Lond), 2024, 24(1):100017. doi:10.1016/j.clinme.2024.100017.
|
[3] |
黄夏宁, 覃鑫, 周洁, 等. 基于纳米孔测序的病原基因组富集技术研究进展与应用前景. 中国口岸科学技术, 2024, 6(z2):28-34. doi:10.3969/j.issn.1002-4689.2024.z2.004.
|
[4] |
张威, 全俊. 非结核分枝杆菌肺病治疗现状及新型治疗药物. 中国感染与化疗杂志, 2022, 22(1): 119-124. doi:10.16718/j.1009-7708.2022.01.024.
|
[5] |
Zheng M, Chen X, Chen Q, et al. Employing Multicolor Melting Curve Analysis to Rapidly Identify Non-Tuberculous Mycobacteria in Patients with Bronchiectasis:A Study from a Pulmonary Hospital in the Fuzhou District of China, 2018—2022. Crit Rev Immunol, 2024, 44(4):41-49. doi:10.1615/CritRevImmunol.2024052213.
|
[6] |
Tan Y, Deng Y, Yan X, et al. Nontuberculous mycobacterial pulmonary disease and associated risk factors in China:A prospective surveillance study. J Infect, 2021, 83(1):46-53. doi:10.1016/j.jinf.2021.05.019.
|
[7] |
Kumar K, Loebinger MR. Nontuberculous Mycobacterial Pulmonary Disease: Clinical Epidemiologic Features, Risk Factors, and Diagnosis: The Nontuberculous Mycobacterial Series. Chest, 2022, 161(3):637-646. doi:10.1016/j.chest.2021.10.003.
|
[8] |
Velagapudi M, Sanley MJ, Ased S, et al. Pharmacotherapy for nontuberculous mycobacterial pulmonary disease. Am J Health Syst Pharm, 2022, 79(6):437-445. doi:10.1093/ajhp/zxab422.
|
[9] |
Nogueira LB, Garcia CN, Costa MSCD, et al. Non-tuberculous cutaneous mycobacterioses. An Bras Dermatol, 2021, 96(5):527-538. doi:10.1016/j.abd.2021.04.005.
pmid: 34275692
|
[10] |
Chapman R, Jones L, D’Angelo A, et al. Nanopore-Based Metagenomic Sequencing in Respiratory Tract Infection: A Developing Diagnostic Platform. Lung, 2023, 201(2):171-179. doi:10.1007/s00408-023-00612-y.
pmid: 37009923
|
[11] |
Lin WH, Tang F, Liu SS. Diagnostic value of nanopore sequencing technology in nontuberculous mycobacterial pulmonary disease. Am J Transl Res, 2024, 16(8):4208-4215. doi:10.62347/HHRH8076.
|
[12] |
Liu Z, Yang Y, Wang Q, et al. Diagnostic value of a nanopore sequencing assay of bronchoalveolar lavage fluid in pulmonary tuberculosis. BMC Pulm Med, 2023, 23(1):77. doi:10.1186/s12890-023-02337-3.
pmid: 36890507
|
[13] |
杨晨, 高卫卫, 郭羿成, 等. 纳米孔靶向测序在分枝杆菌鉴定和耐药基因检测中的研究进展. 中国防痨杂志, 2024, 46(5):578-583. doi:10.19982/j.issn.1000-6621.20240049.
|
[14] |
张述耀, 侯铁英, 黎小妍, 等. 纳米孔测序在病原微生物检测中的应用专家共识. 中国药房, 2024, 35(14):1673-1682. doi:10.6039/j.issn.1001-0408.2024.14.01.
|